Ocular Therapeutix™宣布,计划于2026年2月17日(星期二)公布其针对湿性年龄相关性黄斑变性(Wet AMD)的Sol-1三期优效性试验的顶线数据。
Ocular Therapeutix™宣布,计划于2026年2月17日(星期二)公布其针对湿性年龄相关性黄斑变性(Wet AMD)的Sol-1三期优效性试验的顶线数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.